Clinical Trials Logo

Clinical Trial Summary

This cross-sectional study will evaluate the association between sociodemographic, occupational, clinical conditions, psychological (sense of coherence), sleep quality variables and SB diagnosed by PSG, the gold standard exam with audio-visual resources obtained at Pelotas Sleep Institute.


Clinical Trial Description

Sleep bruxism is defined as a masticatory muscle activity during sleep that is characterised as rhythmic (phasic) or non-rhythmic (tonic) and should be considered a risk factor rather than a disorder in otherwise healthy individuals.

The diagnosis of sleep bruxism often is challenging and despite the use of questionnaires, clinical exams and portable devices, based on current knowledge, the polysomnography with audio-video recordings emerges as the gold-standard criteria for a definite sleep bruxism diagnosis.

Included on the questionnaire there is a registration form, which contains: included: age at time of data collection , gender, marital status , and education level ; Occupational: individuals were asked about work outside home, and working hours; Clinical condition: body mass index, smoking; alcohol consumption; use of sleeping pills; respiratory allergy and Psychological: sense of coherence . ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04015349
Study type Observational
Source Federal University of Pelotas
Contact
Status Completed
Phase
Start date July 1, 2017
Completion date February 1, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04792398 - Bruxism Xeomin® Intervention Trial Phase 4
Completed NCT03825237 - Sleep Architecture and Factors Associated With Definitive Diagnosis of Sleep Bruxism
Completed NCT04934449 - Occlusal Splints in the Treatment of Sleep Bruxism N/A